Headquartered in La Jolla, California, DermTech International develops molecular biology assays to identify, diagnose and/or analyze any number of disease states or conditions, the genetic footprints of which can be found on the stratum corneum by using DermTech's proprietary EGIR technology. A private company, DermTech is supported by venture-backed as well as individual investors. If you wish to learn more, please contact us:

    George Schwartz
    Chief Executive Officer
    DermTech International Inc.
    Ph: (858) 450-4222
    Cel: (619) 417-3285
    gschwartz@dermtech.com